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Introduction: Randomized trials evaluating interventions for stress urinary incontinence (SUI) have been using variable outcome
measures, reporting a variety of outcomes. Alongside this variation across studies, outcome-reporting ﬂaws contribute to a limited
use of research to inform clinical practice. The development and use of core outcome sets (COSs) in future trials would ensure that
outcomes important to different stakeholders and primarily women with SUI are reported more consistently and comprehensively.
Methods:An international steering group including healthcare professionals, researchers, andwomenwith urinary incontinence will
guide the development of this COS. Potential outcomes will be identiﬁed through comprehensive literature reviews. These outcomes
will be entered into an international, multiperspective online Delphi survey. All key stakeholders, including healthcare professionals,
researchers, andwomenwith urinary incontinence, will be invited to participate. Themodiﬁed Delphi method encourages stakeholder
group convergence toward collective agreement, also referred as consensus, core outcomes.
Discussion:Dissemination and implementation of the resulting COSwithin an international context will be promoted and reviewed.
Embedding the COS for SUI within future clinical trials, systematic reviews and clinical practice guidelines could make a signiﬁcant
contribution to advancing the value of research in informing clinical practice, enhancing patient care and improving outcomes. The
infrastructure created by developing a COS for SUI could be leveraged in other settings, for example, selecting research priorities and
clinical practice guideline development.
Abbreviations: COMET = Core Outcome Measures in Effectiveness Trials, COS = core outcome set, COS-STAR = COS–
Standards for Reporting, CROWN = The Core Outcomes in Women’s Health, ICHORSUWH = International Collaboration for
Harmonising Outcomes, Research, and Standards in Urogynaecology and Women’s Health, SUI = stress urinary incontinence.
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11. Introduction
Stress urinary incontinence (SUI) affects millions of women
worldwide.[1] Short- and long-term associated morbidity may
have an effect on quality of life including daily activities,
psychological wellbeing, and sexual function. The efﬁcacy of the
surgical and nonsurgical options to treat SUI has been studied in
various clinical trials[2–5]; however, commonly and highly
effective surgical treatments, such as the mid-urethral slings,
are under scrutiny in the UK, Republic or Ireland, and elsewhere.
Current evidencehasmajorﬂaws. In theabsenceof a standardized
approach in research methodology, most SUI trials have reported
information on various outcomes. For example, safety aspects of
potential treatments for SUI, particularly over the longer term, were
inconsistently evaluated across clinical trials. Even in the unlikely
situationwhere outcomes have been consistently collected, evidence
synthesis can be limited by the use of different outcome measures,
including deﬁnitions and measurement instruments.
Potential new treatments for SUI require an effective evaluation.
The reportingof appropriate outcomes to reﬂect efﬁcacyand safety
of a treatment is a critical step in designing future randomized
trials.[6] To ensure relevance to policy and practice, the chosen
outcomes need to be relevant to key stakeholders (Fig. 1).
The development and use of a collection of well-deﬁned,
discriminatory and feasible outcomes, termed a COS, would help
to address these issues.[7] COS are minimum datasets that can be
Figure 1. Key stakeholders involved in SUI. SUI=stress urinary incontinence.
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the ﬁnal publication.
Our aim is to produce, disseminate, and implement a COS for
SUI according to the Core Outcome Measures in Effectiveness
Trials (COMET) guidelines,[8] following the pathway illustrated
by Figure 2.
2. Methods
2.1. Prospective registration
This study has been prospectively registered with the COMET
initiative (registration number: 981) and is available online
(www.comet-initiative.org/studies/details/981). This project is
led and conducted by CHORUS, An International CollaborationFigure 2. The steps of developing a COS for SUI. COS=
2for Harmonising Outcomes, Research, and Standards in
Urogynaecology and Women’s Health (https://i-chorus.org/).2.2. Creating an international group for the development
of a COS for SUI
An international steering group including healthcare professio-
nals, researchers and women with SUI will guide the development
of a COS that will be applicable to clinical studies evaluating
therapeutic interventions for women with SUI. The development
of effective interventions to reduce the effect of SUI on women’s
quality of life is urgently required, given the ﬂaws and weaknesses
documented in Cochrane reviews.[6–7,9] Also, the scrutiny that
previously considered “criterion standard” procedures such as
the mid-urethral slings are currently undergoing by governmentcore outcome set; SUI=stress urinary incontinence.
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high vigilance regime of restricted practice.[10–11]2.3. Step 1: identifying potential outcomes
Selection of appropriate outcomes is an essential step for study
design, as ultimately any study is only as valuable as its
endpoints.[8] Clinical trials that evaluate beneﬁts and harms of
interventions for SUI must select outcomes of relevance to key
stakeholders and measure them using adequate tools. The main
issues that arise throughout this process are inconsistent
selection, measurement, and reporting of outcomes. A signiﬁcant
challenge is represented by the measurement of outcomes of
interventions for SUI in a variety of ways that ﬁnally leads to
outcome reporting bias. Therefore, the barrier to compare and
highlight differences in clinical trials’ ﬁndings has an inevitable
negative effect on their interpretation and embedding in clinical
practice.
One way to address these issues is by going through a multi-
step pathway (Fig. 2) that has been successfully applied in several
disciplines, to develop, disseminate, and implement COS for
various conditions. This protocol is in line with the COMET
Initiative guidelines and other COS development research
relevant to women’s health including preeclampsia, endometri-
osis, pelvic organ prolapse, among others.[7,12–14]
For the development of this protocol and to evaluate the extent
of existing variations we are currently completing a systematic
review on the variation of outcomes and outcome measures in
SUI randomised trials and we will generate an inventory of
outcomes, outcome measures and deﬁnitions of both to inform
the consensus process. The results will be entered into a modiﬁed
Delphi method. Through the review we also aim to increase the
range of evidence synthesis in SUI interventions ﬁeld and to guide
further research conduct towards the development of a COS.
2.3.1. Systematic review (previously reported outcomes).
We identiﬁed trials evaluating therapeutic interventions for SUI
following a standardized methodology and searches of databases
including PubMed/ Medline, EMBASE, and Cochrane Central
Register of Controlled Trials. We will evaluate publications that
aim to improve the health of women with SUI, including trials
and guidelines on various treatments including surgical inter-
ventions, physical therapies, and behavioral approaches.
2.3.2. Outcome inventory. A comprehensive inventory of
outcomes identiﬁed by systematic reviews will be developed.
Outcome domains will be listed in a database and coded
according to the taxonomy proposed by the COMET Initiative.
If there is uncertainty as to how to classify or present an
outcome, consensus of the steering group will be sought.
Following the steering group’s agreement, the outcome inventory
will be entered into the modiﬁed Delphi method.2.4. Step 2: determining core outcomes
Delphi method involves a series of supervised rounds of surveys.
The modiﬁed Delphi method encourages repeated reﬂection and
rescoring of outcomes.[15] These actions promote whole and
individual stakeholder group convergence upon a consensus of
core outcomes and has advantages over other agreement methods
less standardized. Web-based Delphi surveys facilitate interna-
tional participation and are considered feasible and efﬁcient.[16]3Key stakeholders will be invited to participate in the Delphi
survey. Stakeholders’ selection is meant to ensure inclusion of all
relevant parties with an interest in SUI interventions. As there are
no clear recommendations that we are aware of for the optimum
sample size[16] for a Delphi survey, based upon previous studies,
we will aim to include 20 participants from each stakeholder
group to ensure adequate representation.
The results of round 1 responder participants in each
stakeholder group will be assessed at the end of this round.
They will be presented as total number and/or percentage of: registrations
 respondents who have completed the survey
 respondents who completed the round
 respondents in each stakeholder group
 respondents compared to potential respondents as identiﬁed
from the information provided by clinical leads new respondents who were not included in original invitation
to complete the survey.
2.4.1. Round 1. Participants will be invited to register online,
provide demographic details, and commit to all rounds.[17] They
will be allocated a unique identiﬁer which will make their
responses anonymous. Individual outcomes will be scored by
participants using a 7-point Likert Scale anchored between 1 (not
important) and 7 (critical). This scale has been widely adopted by
COS developers.[18] During the ﬁrst round, participants will be
invited to suggest additional outcomes. Instead of limiting the
variety of outcomes measured and reported across studies, a core
outcome set would establish minimal reporting requirements
while considering individual aspects. Additional outcomes noted
by participants will be reviewed by the outcome committee and, if
novel, listed in round 2. The round will close following a 4-week
window.
2.4.2. Round 2. Participants will present their individual and
stakeholder group responses and they will be invited to reﬂect on
the observed similarities and differences before proceeding to the
next step and scoring individual outcomes again. The round will
close following a 4-week window.
For each outcome, the median and H-spread of scores will be
summarized graphically by stakeholder group and individual
responses. Rescoring outcomes as part of the modiﬁed Delphi
method facilitates agreement upon core outcomes.[19] The
round’s 2 results will be reviewed and analyzed by the steering
group to consider the need for a further Delphi survey round.
This round’s results, as well as the results of any potential
further round, will enable individual outcomes to be classiﬁed as
shown in Table 1.[16] Although subjective, these deﬁnitions and
criteria have been proposed by previous COS developers,[16,20–21]
and help collecting and reporting uniform results.2.5. Stakeholder consultation
This ﬁnal phase will involve a face-to-face meeting with key
stakeholders and viewpoints from participants who have
completed all steps of the survey. The objective of the consensus
meeting will be to discuss consensus outcomes and approve a
ﬁnal COS for SUI interventions. During this meeting, the results
from each round of the Delphi survey will be presented. To avoid
biased consensus formation among group participants, the
steering committee will ensure that the meeting is interactive
Table 1
Consensus status based on core outcome criteria.
Consensus status Description Criteria
Consensus in Classify as a core outcome Over 70% of participants in each stakeholder group score this outcome domain “critical” AND
Less than 15% of participants in each stakeholder group score outcome domain “not important.”
Consensus out Do not classify as a core outcome Over 70% of participants in each stakeholder group score outcome domain “not important” AND
Less than 15% of participants in each stakeholder group score outcome domain “critical.”
Lack of consensus Do not classify as a core outcome Anything else
Rada et al. Medicine (2019) 98:37 Medicineand considers all opinions. To facilitate dissemination and
implementation, professional society representatives, editors
from key journals, and funders of SUI research[22–23] will be
invited to take part in this meeting.3. Discussion
As with previous COS development projects, this project is not
directly inﬂuencing patient safety,[12,24–25] and therefore, ethics
approval was not required. Also, The Medical Research Council
decision tool that helps to determine whether a research project
conducted within the UK requires approval from an NHS
Research Ethics Committee (REC) indicated that this research
does not require REC approval.
All involved participants will be asked for their consent
(Supplemental Digital Content (Appendix 1, http://links.lww.
com/MD/D220)) before participating in either stakeholder
meetings or the Delphi survey and all procedures will be
conducted according to the Declaration of Helsinki.[25] A “no-
response” option will be allowed both for the survey and
interactive parts of the research to ensure responder‘s right to
withhold information. A speciﬁc timeframe of the Delphi
process will be provided and information concerning the
interval of data storage and handling will be made available
to participants.
This COS development protocol will follow COS–Standards
for Reporting (COS-STAR) statement and checklist.[26] As
dissemination is the crucial step in the effective application of
trial outcomes, awareness must be increased among all involved
parties to ensure widespread use of this COS in SUI interventions
research and proper reporting.
Implementing COS in future clinical studies, systematic
reviews and clinical guidelines could make a profound
contribution to advancing the reach and relevance of research
in informing clinical practice, enhancing patient care and
improving intervention outcomes for women suffering from
SUI. Mapping all outcomes reported in clinical trials assessing
interventions for SUI in women will provide basis for offering
best patient care for these patients.3.1. Improving clinical trial outcome selection
Standard Protocol Items-Recommendations for Interventional
Trials (SPIRIT) supported by funders of health research,
recommend the use of COS where they exist.[27] This study
protocol was designed to the SPIRIT checklist.[27] A COS that
would hopefully ensure that consensus outcomes important to all
stakeholders, including women with SUI are properly collected
and reported. When clinical studies use consensus outcomes and
outcome measures, meta-analyses, using individual patient data
are feasible.43.2. Improving clinical trial reporting and evidence
synthesis
The Core Outcomes in Women’s Health (CROWN) initiative,
supported by several journals, have already implemented
COS.[23] Participating journals will require authors to report
the results for core outcomes within trial reports and systematic
reviews and offer conclusions based on these outcomes rather
than non-core or surrogate outcomes.Where COSs have not been
collected, the authors will be asked to report this limitation and
its effect for their ﬁndings.[22]3.3. Improving clinical practice guidelines
The National Institute for Health and Care Excellence (NICE)
supports the use of COS when selecting outcomes during
evidence scoping and synthesis.[8] As this activity forms the basis
of updating guideline recommendations, the COS could have a
direct effecr in improving clinical practice.Acknowledgments
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